4
Changes in Ownership
Estrella Immunopharma, Inc. Filed Acc 0001213900-25-014306
Options or other derivatives
- Chief Financial Officer acquired 1,000,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Xu Jiandong · Chief Financial Officer
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-10-30 | Grant or award : show line 1 in the form Incentive Share Option | +490,796 | 490,796 | D |
| 2024-10-30 | Grant or award : show line 2 in the form Nonstatutory Share Option | +509,204 | 509,203 | D |
Loading xslF345X05/ownership.xml…